Director, Health Economics and Outcomes Research (HEOR)

Mineralys Therapeutics is a publicly traded, clinical-stage biotechnology company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. Our initial product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that we are developing for cardiorenal conditions affected by abnormally elevated aldosterone, including hypertension and chronic kidney disease.

Mineralys is a fully remote company.

For more information, please visit https://mineralystx.com. Follow Mineralys on LinkedIn.

About the Role 

Reporting to the Senior Director, Medical Affairs, the Director of Health Economics and Outcomes Research (HEOR) will lead the development and execution of evidence strategies that support the clinical and economic value of our innovative therapy. This high-impact role will shape the value proposition for payers, providers, and patients as we advance toward the commercialization of lorundrostat. 

As a key member of the Medical Affairs team, the Director will be responsible for designing and delivering real-world evidence (RWE), economic modeling, and outcomes research that informs market access and pricing decisions in the U.S. The ideal candidate is a hands-on leader who thrives in a fast-paced, entrepreneurial environment and is passionate about improving patient care through data-driven insights. 

Key Responsibilities 

Evidence Generation 

• Oversee data analysis and contribute to research reports for internal and external consumption. 

• Collaborate with the Medical Value and Outcomes team to ensure alignment with customer needs. 

• Partner cross-functionally with Medical Affairs, Clinical Development, Market Value & Access and Commercial teams to align with data needs. 

• Design and manage RWE and HEOR studies (e.g., cost-effectiveness analysis, burden of illness, treatment patterns, claims/EMR analysis, and patient-reported outcomes). 

• Manage external research vendors, academic collaborators, and data sources to execute HEOR and RWE initiatives. 

Value and Access 

• Lead the development and execution of the HEOR strategy to support product differentiation, access, and reimbursement. 

• Collaborate with Market Access to develop a compelling value proposition. 

• Lead or support payer advisory boards, KOL engagements, and HEOR expert panels to gather insights that shape research priorities and data communication strategies. 

• Monitor the competitive landscape for HEOR data, models, and payer strategies; provide insights to inform product positioning. 

• Stay current on evolving payer requirements, HTA frameworks, and healthcare policy developments. 

Communications and Publications 

• Develop pre-approval information exchange resources, AMCP dossiers, payer communication tools (e.g., value decks), and health economic models (e.g., budget impact models). 

• Lead publication planning and execution of HEOR deliverables in peer-reviewed journals and scientific congresses. 

Ensure all HEOR activities adhere to internal SOPs, regulatory standards, and ethical guidelines for RWD and economic modeling. 

Qualifications 

• Advanced degree (PhD, PharmD, MD, MPH, or similar) in health economics, epidemiology, outcomes research, public health, or related discipline. 

• Minimum of 8 years of U.S. industry experience in HEOR, RWE, or Market Access within U.S. pharmaceutical, biotech, or healthcare consulting settings. 

• Proven experience supporting U.S. product launches